Dapiprazole

Dapiprazole
Clinical data
AHFS/Drugs.com	Consumer Drug Information
MedlinePlus	a601043
Pregnancy; category	B;
Routes of; administration	Topical (eye drops)
ATC code	S01EX02 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Pharmacokinetic data
Bioavailability	Negligible when administered topically
Identifiers
	IUPAC name 3-{2-[4-(2-methylphenyl)piperazin-1-yl]ethyl}-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,5-a]pyridine;
CAS Number	72822-12-9 ;
PubChem CID	3033538;
IUPHAR/BPS	7155;
DrugBank	DB00298 ;
ChemSpider	2298190 ;
UNII	5RNZ8GJO7K;
KEGG	D07775 ;
ChEBI	CHEBI:51066 ;
ChEMBL	ChEMBL1201216 ;
CompTox Dashboard (EPA)	DTXSID90223140 ;
Chemical and physical data
Formula	C19H27N5
Molar mass	325.460 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES n1nc(n2c1CCCC2)CCN4CCN(c3ccccc3C)CC4;
	InChI InChI=1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3 ; Key:RFWZESUMWJKKRN-UHFFFAOYSA-N ;
	(what is this?) (verify)

Dapiprazole (brand name Rev-Eyes) is an alpha-1 blocker. It is used to reverse mydriasis after eye examination.^[1]

Quick Facts Clinical data, AHFS/Drugs.com ...

References